{"id":53202,"date":"2023-01-23T19:02:25","date_gmt":"2023-01-23T18:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dna-methylation-market-report-2022-increasing-adoption-of-dna-methylation-technology-in-oncology-research-bolsters-growth-researchandmarkets-com\/"},"modified":"2023-01-23T19:02:25","modified_gmt":"2023-01-23T18:02:25","slug":"dna-methylation-market-report-2022-increasing-adoption-of-dna-methylation-technology-in-oncology-research-bolsters-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dna-methylation-market-report-2022-increasing-adoption-of-dna-methylation-technology-in-oncology-research-bolsters-growth-researchandmarkets-com\/","title":{"rendered":"DNA Methylation Market Report 2022: Increasing Adoption of DNA Methylation Technology in Oncology Research Bolsters Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “DNA Methylation Market Size, Share & Trends Analysis Report By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region, And Segment Forecasts, 2022 – 2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global DNA methylation market size is expected to reach USD 4.22 billion by 2030. The market is expected to register a CAGR of 14.67% from 2022 to 2030, due to the increased usage of DNA methylation in sequencing analysis. The increased adoption of DNA methylation in the agrigenomics field remains a promising driver of this growth.\n<\/p>\n

\nIn January 2020, a research journal published in Springer stated that DNA methylation and expression analysis shows peanut foliar disease resistance genes have epialleles. DNA methylation analysis continues to open new doors of opportunities for researchers, and pharmaceutical companies. Increased research and developments in this field would further drive the DNA methylation industry in the coming years.\n<\/p>\n

\nFurthermore, the growing prevalence of esophageal adenocarcinoma has contributed to the overall growth. According to the data published by the American Cancer Society (ACS), in 2022, an estimated 20,640 esophageal cancer cases were undiagnosed in the U.S. The chronic disease resulted in 16,410 deaths.\n<\/p>\n

\nGrowing esophageal cancer cases in the U.S. highlight the urgent need for early intervention measures that can help improve the low survival rates for patients. In October 2022, a research article published by Fred Hutchinson Cancer Center stated that methylated DNA biomarkers could be used for the detection of esophageal adenocarcinoma and high-grade dysplasia.\n<\/p>\n

\nThe significant increase in the adoption of epigenetics-based treatment strategies, coupled with the broad nucleic acid-based diagnostic tests & kits commercialization is projected to drive the growth of the market. In May 2022, an article published in PubMed stated that theepigenetics-based treatment strategies are to be used for studying Alzheimer’s disease. However, a lack of expertise to perform DNA methylation experiments could restrict the growth. DNA methylation holds significant potential in various biotechnology applications, while the relatively low number of skilled professionals remains an obstacle to growth.\n<\/p>\n

\nDNA Methylation Market Report Highlights<\/strong>\n<\/p>\n